The team at Dr.Hempdog prides itself on leading with science, which is why we ensure that everything we sell is backed up by extensive clinical research (all of which is easily available on this website). Thanks to all the research done by the scientific community and our extensive experience in the industry, we know that the future of cannabinoid science is bright.
However, veterinary cannabinoid trials are currently moving slower than they could, and we know that cannabinoids can be further leveraged to help animals in need right now. In order to help move the science forward, we've taken the lead and initiated several groundbreaking clinical trials. We are blessed to have prominent veterinarians and trainers be part of our studies, and we hope the rest of the veterinary community gets on board too.
Below, you'll find a summary of our pilot CBN trial, alongside a link to a full overview of the study. We hope you'll be as impressed as we are with the initial results of this first-of-its-kind study for the safety and efficacy of CBN in dogs.
OUR CBN (CANNABINOL) FOR CANINE ANXIETY TRIAL
START DATE: AUGUST 2021 ♦ STATUS: ONGOING
The purpose of this clinical trial is to research the safety and effectiveness of the cannabinoid CBN (coupled with a full-spectrum Hemp Oil) for dogs with severe anxiety. Before this trial, Dr.Hempdog had already worked with this formula for 18 months with very promising results. Because of that success, we created a formal clinical trial to capture and demonstrate this evidence.
This is the first-ever clinical trial to study the anti-anxiety effects of CBN in dogs (that we know of). We are honored to have a group of accomplished veterinarians, dog trainers, and canine wellness professionals taking part in all stages of this trial.
Our first group of 10 dogs is already 90 days into the study. Each dog is receiving daily doses of our proprietary full-spectrum CBN/CBD oil (i.e. our Ultra Behavior Formula). As time goes on, we're adding more groups of dogs to the study.
Why This Research is Important:
Since we started servicing dogs with anxiety back in 2015, we noticed that our full-spectrum hemp oil was very useful for anxiety; however, there were still some dogs in some situations that it wasn't able to fully assist. This frustrated us to no end.
Because of our deep knowledge of cannabinoid science, we've known for a long time that CBN could have a positive influence on anxiety.
Over the years, we started to experiment with CBN on ourselves (like we do with most cannabinoids). After that, we started testing very small, safe doses with a few dogs we knew well that were good candidates. We learned that proper dosing is essential to have success with using this cannabinoid for anxiety, so we extensively studied CBN coupled with combinations of other cannabinoids. Based on this, we developed the most effective formula possible. Our continued experiments were incredibly successful, so we initiated a formal clinical trial to capture and further elaborate on this evidence.
Thanks to advances in our cultivation capabilities, we are now able to grow very high-quality CBN from hemp for this purpose, allowing us to create this next-generation cannabinoid product. This product is legal in all fifty states.
Latest Public Update:
Day 90: November 29, 2021
Ninety days in, every dog (while remaining at the same dose as the last update) continues to see reduced anxiety symptoms, and their humans report seeing continually improving quality of life. All dogs in Group A will continue to use the same dose for the remainder of the trial, and their humans will provide updates every 30 days.
No side effects have been observed at any stage of the trial thus far in any of the dogs in Group A.
ACCESS MORE UPDATES AND TRIAL INFO
Click the button below to view a detailed breakdown of the UBF trial.⯈ View UBF Trial Details
We're constantly onboarding new dogs, scientists, and veterinarians. If you're interested in getting involved, you can contact us through this details page.
OTHER TRIALS WILL BE LISTED HERE ONCE ANNOUNCED
In the future, trial data will be posted to this page for public viewing as soon as possible.